Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PALISADE BIO, INC. Director's Dealing 2010

Jul 12, 2010

35274_dirs_2010-07-12_f6ec6de1-5197-489e-8153-65af2b0d03d6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2010-07-08

Reporting Person: GARR RICHARD (CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-07-08 Common Stock A 76953 Acquired 1490148 Direct

Footnotes

F1: On July 8, 2010, Reporting Person was issued 76,953 common shares. The issuance was previously approved on March 30, 2010 by
the Issuers Compensation Committee as part of Reporting Person's 2009 incentive bonus award. The common shares awarded may
not be sold by Reporting Person for a period of five years unless there is a "change of control" or termination of
employment.